NCT00942968 2024-04-18
Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer
Pfizer
Phase 4 Completed
Pfizer
Alliance Foundation Trials, LLC.
Academic and Community Cancer Research United
Daiichi Sankyo
Assistance Publique - Hôpitaux de Paris